123Everard A, Matamoros S, Geurts L, Delzenne NM, Cani PD (2014) Saccharomyces boulardii
administration changes gut microbiota and reduces hepatic steatosis, low-grade inflamma-
tion, and fat mass in obese and type 2 diabetic db/db mice. mBio 5:e01011–e01014
Fang JS, Gillies RD, Gatenby RA (2008) Adaptation to hypoxia and acidosis in carcinogenesis
and tumor progression. Semin Cancer Biol 18:330–337
Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A,
Vigneri R (1999) Insulin receptor isoform A, a newly recognized, high-affinity insulin-like
growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19:3278–3288
Gatto EM, Riobo NA, Carreras MC, Chernavsky A, Rubio A, Satz L, Poderoso JJ (2000)
Overexpression of neutrophil neuronal NOS in Parkinson’s disease. NO 4:534–539
Ghosh HS, McBurney M, Robbins PD (2010) SIRT1 negatively regulates the mammalian target
of rapamycin. PLoS ONE 5:e9199
Gillies RJ, Gatenby RA (2007) Adaptive landscapes and emergent phenotypes: why do cancers
have high glycolysis? J Bioenerg Biomembr 39:251–257
Gong Y, Dou LJ, Liang J (2014) Link between obesity and cancer: role of triglyceride/free fatty
acid cycling. Eur Rev Med Pharmacol Sci 18:2808–2820
Good PF, Hsu A, Werner P, Perl DP, Olanow CW (1998) Protein nitration in Parkinson’s disease.
J Neuropathol Exp Neurol 57:338–342
Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell
140:883–899
Gu ZZ, Nakamura T, Lipton SA (2010) Redox reactions induced by nitrosative stress medi-
ate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol
Neurobiol 41:55–72
Hahn T, Barth S, Hofmann W, Reich O, Lang I, Desoye G (1998) Hyperglycemia regulates
the glucose-transport system of clonal choriocarcinoma cells in vitro. A potential molecu-
lar mechanism contributing to the adjunct effect of glucose in tumor therapy. Int J Cancer
78:353–360
Han L, Ma Q, Li J, Liu H, Li W, Ma G, Xu Q, Zhou S, Wu E (2011) High glucose promotes pan-
creatic cancer cell proliferation via the induction of EGF expression and transactivation of
EGFR. PLoS ONE 6:e27074
Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, Peggie MW,
Zibrova D, Green KA, Mustard KJ, Kemp BE, Sakamoto K, Steinberg GR, Hardie DG
(2012) The ancient drug salicylate directly activates AMP-activated protein kinase. Science
336:918–922
Heinrichsdorff J, Olefsky JM (2012) Fetuin-A: the missing link in lipid-induced inflammation.
Nat Med 18:1182–1183
Henao-Meijia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth
SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, Flavell RA (2012)
Inflammasome-mediated dysbiosis regulates progression of NALFD and obesity. Nature
482:179–185
Hjelmeland AB, Wu Q, Heddleston JM, Choudhary GS, MacSwords J, Lathia JD, McLendon R,
Lindner D, Sloan A, Rich JN (2011) Acidic stress promotes a glioma stem cell phenotype.
Cell Death Differ 18:829–840
Ibrahim M, Farghaly E, Goma W, Kelleni M, Abdelrahman AM (2011) Nitro-aspirin is a poten-
tial therapy for non alcoholic fatty liver disease. Euro J Pharmacol 659:289–295
Ignarro LJ (2010) NO: biology and pathobiology, 2nd edn. Elsevier, Amsterdam
Imajo K, Fujita K, Yoneda M, Nozaki Y, Ogawa Y, Shinohara Y, Kato S, Mawatari H, Shibata W,
Kitani H, Ikejima K, Kinkoshi H, Nakajima N, Saito S, Maeyama S, Watanabe S, Wada K,
Nakajima (2012) Hyperresponsibility to low-does endotoxin during progression to nonalco-
holic steatohepatitis is regulated by leptin-mediated signaling. Cell Metab 16:44–54
Ischiropoulos H (2009) Protein tyrosine nitration: an update. Arch Biochem Biophys
484:117–121
References